Hanneke Later-Nijland

Attorney-at-law at Genome Lawyers

Speaker

Hanneke is the only lawyer-pharmacist holding a PhD in the Netherlands. She specialises in EU and national (bio)pharma law.

Hanneke holds a PhD in clinical pharmacokinetics and she is also a former Inspector for Clinical Trials and Pharmacovigilance at the Netherlands Inspectorate for Healthcare (“IGJ”). This unique combination of a dual background as well as relevant experience at the competent authority gives her a unique perspective and understanding of the Life Sciences sector.

In her practice, Hanneke advises life sciences and healthcare clients and litigates on a wide range of issues, often with a regulatory focus. Her areas of expertise in the medicinal products field covers the interface between regulatory and patent law, marketing authorisations, market access, reimbursement, clinical trials, GxP compliance, pharmacovigilance, and advertising issues. A large part of her practice entails assisting clients with regulatory issues in the context of transactions in the life sciences sector. In 2022, Hanneke has launched the only global network of Regulatory and Corporate lawyers, who focus on life sciences transactions: The Genotype Network.

Lastly, she is a lecturer at Leiden University and a frequent speaker at international life sciences conferences.